Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. [electronic resource]
Producer: 20081204Description: 1003-11 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Docetaxel
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride
- Etoposide -- administration & dosage
- Female
- Gene Amplification
- Humans
- In Situ Hybridization, Fluorescence
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Remission Induction
- Survival Rate
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.